Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression

NCT02919462 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped low recruitement rate

Conditions

Carcinoma, Non-Small-Cell Lung
Secondary
Advanced Stage IIIB
High Thymidylate Synthase Expression

Interventions

DRUG: Oral vinorelbine
DRUG: Cisplatin
DRUG: Maintenance with Metronomic Oral Vinorelbine
DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Maintenance with Pemetrexed

Sponsor

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Collaborators

[object Object]